相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
Elizabeth M. Perez et al.
ONCOTARGET (2017)
Epstein-Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses-A 10-Year Follow-up of a Swedish Birth Cohort
Gintare Lasaviciute et al.
FRONTIERS IN IMMUNOLOGY (2017)
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
Hongyan Liu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
Britta S. Moehl et al.
MOLECULES AND CELLS (2016)
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
Xinle Cui et al.
VACCINE (2016)
Epstein-Barr virus: more than 50 years old and still providing surprises
Lawrence S. Young et al.
NATURE REVIEWS CANCER (2016)
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Masaru Kanekiyo et al.
CELL (2015)
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
Javier Gordon Ogembo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
The role of Epstein-Barr virus in epithelial malignancies
Sai-Wah Tsao et al.
JOURNAL OF PATHOLOGY (2015)
Epstein-barr virus vaccines
Jeffrey I. Cohen
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Repertoire of Epitopes Recognized by Serum IgG from Humans Vaccinated with Herpes Simplex Virus 2 Glycoprotein D
J. Charles Whitbeck et al.
JOURNAL OF VIROLOGY (2014)
Dissection of the Antibody Response against Herpes Simplex Virus Glycoproteins in Naturally Infected Humans
Tina M. Cairns et al.
JOURNAL OF VIROLOGY (2014)
Progress, prospects, and problems in Epstein-Barr virus vaccine development
Henry H. Balfour
CURRENT OPINION IN VIROLOGY (2014)
Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
Gulfaraz Khan et al.
INFECTIOUS AGENTS AND CANCER (2014)
A novel tetrameric gp3501-470 as a potential Epstein-Barr virus vaccine
Xinle Cui et al.
VACCINE (2013)
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Javier G. Ogembo et al.
CELL REPORTS (2013)
Fc-fusion proteins: new developments and future perspectives
Daniel M. Czajkowsky et al.
EMBO MOLECULAR MEDICINE (2012)
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel et al.
LANCET ONCOLOGY (2012)
Strategies for extended serum half-life of protein therapeutics
Roland E. Kontermann
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Efficient mucosal vaccination mediated by the neonatal Fc receptor
Lilin Ye et al.
NATURE BIOTECHNOLOGY (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice
Krishnamurthy Konduru et al.
VACCINE (2011)
Polymeric human Fc-fusion proteins with modified effector functions
David N. A. Mekhaiel et al.
SCIENTIFIC REPORTS (2011)
On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis
Miranda M. C. van Beers et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Optimal treatment for chronic active Epstein-Barr virus disease
Jeffrey I. Cohen
PEDIATRIC TRANSPLANTATION (2009)
A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
Lesley Rees et al.
TRANSPLANTATION (2009)
Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay
Junji Sashihara et al.
VIROLOGY (2009)
Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes
Hal M. Hoffman et al.
ARTHRITIS AND RHEUMATISM (2008)
A Novel ICOS-Independent, but CD28-and SAP-Dependent, Pathway of T Cell-Dependent, Polysaccharide-Specific Humoral Immunity in Response to Intact Streptococcus pneumoniae versus Pneumococcal Conjugate Vaccine
Quanyi Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
Etienne M. Sokal et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)
Kendra A. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
Michel Moutschen et al.
VACCINE (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Structure of the Epstein-Barr virus major envelope glycoprotein
Gerda Szakonyi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells
M Urquiza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins
WL Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Proteins of purified Epstein-Barr virus
E Johannsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes
M Urquiza et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Epstein-Barr virus infection.
JI Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
